Neonatal signs after in utero exposure to selective serotonin reuptake inhibitors.
Lavenstein
Bennett
B
D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D018730:Infant Behavior / Q000187:drug effects*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome; D013577:Syndrome
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors